Rezultati pretraživanja
  1. 30. srp 2019.

    Gilead, Novartis cancer therapies losing patients to experimental treatment - - -

  2. 18. pro 2017.

    There has been an explosion of immuno-oncology in the past few years, but recent concerns stress the importance of not over saturating this area. Read more from here:

  3. 1. velj 2019.

    An interesting read. A new appreciation for how hard it is to develop drugs. Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard via

  4. 19. kol 2019.
  5. 26. pro 2019.
  6. 2. lis 2019.

    23andMe, moving beyond consumer DNA tests, is building a clinical trial recruitment business.

  7. The lack of diversity and inclusion in clinical trial recruitment hinders advances in biopharmaceutical research and development. Via

  8. 18. srp 2019.

    Useful to see trials presented in this way. A bird’s-eye view of clinical trials provides new perspectives on drug research and development via

  9. 3. lip 2019.

    Half of Patients Are Women. Most Subjects Are Men

  10. 16. lip 2017.
  11. 16. ruj 2016.

    Shares of plummet 84% after respiratory disease fails in .

  12. 11. srp 2016.
  13. 7. ožu 2015.

    MT : Despite FDA moves, push continues for Congress to act on mobile health:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.